Skip to main content
OpenTrials
Completed

NCT Number: NCT06503913

Cognitive Muscular Therapy for Patients With Long-COVID and Breathing Pattern Disorder

The aim of the study is to test a treatment known as "Cognitive Muscular Therapy (CMT)" for reducing breathlessness and improving autonomic function in patients with long-COVID.

Completed

Looking for future studies?

Notify Me

Key information

About this study

A key symptom of long-COVID is dysfunctional breathing, characterised by an alteration in the muscular and mechanical control of breathing, such as altered movement/coordination of diaphragm and ribs. Long-COVID patients also experience symptoms such as dizziness and fatigue, which have been linked to dysautonomia (dysfunction of the nervous system controlling automatic body functions). Importantly, dysautonomia is connected to alterations in breathing mechanics. Specifically, rapid breathing, high in the chest, is associated with increased activity in the fight-or-flight system and decreased activity in the rest-and-repair system. Given this link, interventions capable of improving breathing mechanics could alleviate many long-COVID symptoms. However, current breathing retraining methods lack visualisation of breathing mechanics and do not integrate a whole-body approach to improving postural control.

We have developed a clinical system which can visualise breathing mechanics in real-time, providing patients with a "window into their body". We propose to integrate this system within a new intervention, known as Cognitive Muscular Therapy (CMT). CMT integrates psychological informed physiotherapy with training to reduce overactivation of postural muscles which can interfere with the mechanics of breathing. We propose to test this combined intervention on 20 people with Long-COVD to understand if we can improve respiratory function and symptoms associated with dysautonomia. If successful, this pilot study could pave the way for large-scale studies in long-COVID

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Above 18 years old
  • Experience moderate/severe breathlessness, quantified using the Modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) scale.
  • Speak and understand English sufficiently to read the information sheet and sign the consent form
  • Ability to stand without any assistive device for at least 20 minutes (to ensure sufficient capacity to complete the intervention)

Exclusion criteria

  • Dementia or other major cognitive impairment
  • BMI >32 (as increased subcutaneous fat prevents use of breathing measurement system)
  • Current smoker or smoked regularly within last 6 months
  • Any cardiorespiratory disease that requires medical intervention (except asthma management)
  • Currently receiving physiotherapy-based treatment for LC or breathing pattern disorder
  • Significant respiratory co-morbidity (e.g. COPD, uncontrolled Asthma)

Treatment and study plan

Cognitive Muscular Therapy

Behavioral

Psychologically informed physiotherapy which integrates training to reduce overactivity of postural muscles which can interfere with the mechanics of breathing.

Breathing visualisation

Behavioral

Breathing visualisation; Data from two 3D camera are combined and used to calculate respiratory volumes. These volumes are then used to drive an animation of breathing so that the patient can understand how their breathing pattern compares to an optimal pattern. Note this is not a medical device as data from this system is only used for education and not for diagnostic or treatment decisions.

Primary outcomes

  1. Change in Nijmegen Questionnaire

    Time frame: Change from Baseline to two months (post intervention) & change from Baseline to 5 months (post intervention)

    Used to capture breathlessness symptoms associated with hyperventilation disorder. Score 0 - 60 (0 = no hyperventilation symptoms, 60 severe symptoms of hyperventilation).

Secondary outcomes

  1. Change in Modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) scale

    Time frame: Change from Baseline to two months (post intervention) & change from Baseline to 5 months (post intervention)

    Used to capture breathlessness symptoms associated with long-COVID compared to pre-acute infection. Score 0 - 45 (0 = no long-COVID symptoms, 45 severe symptoms of long-COVID).

  2. Change in Dyspnea-12 questionnaire

    Time frame: Change from Baseline to two months (post intervention) & change from Baseline to 5 months (post intervention)

    Used to capture breathlessness symptoms. Score 0 - 36 (0 = no breathlessness symptoms, 36 severe breathlessness).

  3. Change in Self-evaluation of breathing questionnaire

    Time frame: Change from Baseline to two months (post intervention) & change from Baseline to 5 months (post intervention)

    Used to capture breathlessness symptoms associated with dysfunctional breathing. Score 0 - 75 (0 = no dysfunctional breathing symptoms, 60 severe symptoms of dysfunctional breathing).

  4. Change in Composite Autonomic Symptom Score

    Time frame: Change from Baseline to two months (post intervention) & change from Baseline to 5 months (post intervention)

    Used to capture symptoms associated with autonomic dysfunction. 31 questions rating the symptoms associated with autonomic dysfunction.

  5. Change in EQ-5D-5L

    Time frame: Change from Baseline to two months (post intervention) & change from Baseline to 5 months (post intervention)

    Used to capture an individual's quality of life through their ability to complete daily living activities. Each heading is rated from no problems through to unable to complete the task.

  6. Change in WHO Disability Assessment Schedule (12-item)

    Time frame: Change from Baseline to two months (post intervention) & change from Baseline to 5 months (post intervention)

    Used to capture an individual's ability to perform daily living activities. Each point is rated from No difficulty performing a task to extreme difficulty/cannot complete the task.

Sponsors and collaborators

Lead sponsor

University of Salford

Other

Registry information

Official study title

Cognitive Muscular Therapy for Patients With Long-COVID (Post COVID-19) and Breathing Pattern Disorder

Acronym: COMLOC

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Jul 16, 2024
Registry last updated
May 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.